438
US Weight Loss Pill Approval for Denmark's Novo Nordisk | The Pulse 12/23
Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co.
Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved t…
Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved t…